HIV 1 News and Research

RSS

Homeless rape victims are not seeking post-sexual assault medical care

Nearly three-fourths of young adults experiencing homelessness who are raped do not seek post-sexual assault medical care, missing an opportunity to greatly reduce their risk of contracting HIV, according to a survey led by The University of Texas Health Science Center at Houston.

16 Dec 2019

Study shows non-TB lung infections rising; more in women and older people

Each year, more and more people are getting mycobacterial lung infections, and the total number living with such diseases is going up, according to a new study published in the journal Annals of the American Thoracic Society. Those at greatest risk are people above the age of 65 years and the elderly.

15 Dec 2019

Novel HIV vaccine shows promise

There are millions living with HIV and researchers have been working towards making a successful vaccine against the deadly infection for the past 35 years with no success. Now a new blueprint is being developed to prevent the infection.

15 Dec 2019

UAB seminar on the extraordinary science of the immune system

"The human immune system makes my head explode," Pulitzer Prize-winning journalist Matt Richtel recently told a University of Alabama at Birmingham freshman seminar on immunology. "This is by far the hardest subject I have ever had to explore."

15 Dec 2019

New structure for HIV-1 viral shell proposed

The matrix shell of the HIV-1 virus may have a different shape than previously thought, and a newly proposed model has significant implications for understanding how the virus functions, according to a new study by University of Alberta scientists.

14 Dec 2019

Rectal microbes could make a difference to the effectiveness of HIV vaccines

Microbes living in the rectum could make a difference to the effectiveness of experimental HIV vaccines, according to researchers at the University of California, Davis. The work is published Dec. 11 in the journal mSphere.

13 Dec 2019

House drug pricing bill to reduce costs, improve access to life-saving therapies

H.R. 3, the Elijah E. Cummings Lower Drug Costs Now Act passed by the House of Representatives today introduces critically needed and significant steps to reduce costs and improve access to life-saving therapies for conditions including HIV and hepatitis C.

13 Dec 2019

Bans restricting e-cigarette sales could do more harm than good, say experts

Bans and other policies restricting e-cigarette sales could do more public harm than good, according to a group of public-health, tobacco-policy and ethics experts.

13 Dec 2019

People living with HIV are willing to risk near-certain death in clinical trial

Nearly one-quarter of people living with HIV were willing to risk near-certain death in a clinical trial, if volunteering for the trial would help find a cure for the disease, according to the new study "HIV Cure Research."

13 Dec 2019

Efforts to prevent new HIV transmissions must also focus on people already living with HIV

Efforts to prevent new HIV transmissions in the United States must be accompanied by advances in addressing HIV-associated comorbidities to improve the health of people already living with HIV, National Institutes of Health experts assert in the third of a series of JAMA commentaries.

11 Dec 2019

Nano-sized vesicles released by bacteria may protect against HIV infection

Nano-sized vesicles released by certain bacteria that inhabit the vagina may protect against HIV infection, suggests a study of human cells and tissues by researchers at the National Institutes of Health and the University of Bologna, Italy. Known as extracellular vesicles, these bubble-like particles are produced by many kinds of cells and are thought to transport molecules from one cell to another.

11 Dec 2019

High HIV infection rates attributed to transgender community's social stigmatization and isolation

Although HIV infection rates are high among the transgender community in Russia, many transgender people know very little about the virus, as well as their own health status.

9 Dec 2019

Experts say cancer research is making more progress that people think

The focus on a “cure for cancer” is masking progress made in extending lifespan and making cancer manageable in the long-term.

9 Dec 2019

New approach to broadly acting, highly effective HIV vaccine

Researchers have reported a major advance in the creation of a successful HIV vaccine that is not produced by the host animal.

9 Dec 2019

New technique holds promise in cancer research and science studies

A new technique reported this week in Science overcomes several limitations of typical high-throughput chemical screens conducted on cell samples. Such screens are commonly used to try to discover new cancer drugs, and in many other biomedical applications.

8 Dec 2019

Common first-line treatment for cryptococcal meningitis in being compromised by drug resistance

A common first-line treatment approach for cryptococcal meningitis in low-income countries is being compromised by the emergence of drug resistance, new University of Liverpool research warns.

8 Dec 2019

Common treatment for cryptococcal meningitis compromised by emergence of drug resistance

A common first-line treatment approach for cryptococcal meningitis in low-income countries is being compromised by the emergence of drug resistance, new University of Liverpool research warns.

6 Dec 2019

A 'once a month' birth control pill

Birth control pills in their present form need to be taken once a day each day for the whole menstrual cycle. Other options such as Intra-Uterine devices (IUDs) or implanted progesterone offer a longer coverage, but most women prefer the pills due to their reliability and cheaper, easier and safer usage profile.

5 Dec 2019

No differences found in survival, acute rejection in patients receiving lungs from increased-risk donors

Cleveland Clinic researchers have found that using lungs from donors who are considered high risk for certain infectious diseases compared to standard risk donors results in similar one-year survival for recipients. In addition, researchers saw no difference in rejection or graft (donor lung) survival after one year in patients receiving lungs from increased-risk donors.

5 Dec 2019

Experts condemn CRISPR babies research as original manuscript is made public

Scientists have criticized the gene-editing of the Chinese twins last year, following the first public release of the research.

4 Dec 2019

HIV 1 News and Research

Homeless rape victims are not seeking post-sexual assault medical care

Study shows non-TB lung infections rising; more in women and older people

Novel HIV vaccine shows promise

UAB seminar on the extraordinary science of the immune system

New structure for HIV-1 viral shell proposed

Rectal microbes could make a difference to the effectiveness of HIV vaccines

House drug pricing bill to reduce costs, improve access to life-saving therapies

Bans restricting e-cigarette sales could do more harm than good, say experts

People living with HIV are willing to risk near-certain death in clinical trial

Efforts to prevent new HIV transmissions must also focus on people already living with HIV

Nano-sized vesicles released by bacteria may protect against HIV infection

High HIV infection rates attributed to transgender community's social stigmatization and isolation

Experts say cancer research is making more progress that people think

New approach to broadly acting, highly effective HIV vaccine

New technique holds promise in cancer research and science studies

Common first-line treatment for cryptococcal meningitis in being compromised by drug resistance

Common treatment for cryptococcal meningitis compromised by emergence of drug resistance

A 'once a month' birth control pill

No differences found in survival, acute rejection in patients receiving lungs from increased-risk donors

Experts condemn CRISPR babies research as original manuscript is made public

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News